REMUS
Start SIP
Invest Now
Start SIP in REMUS
Performance
- Low
- ₹695
- High
- ₹729
- 52 Week Low
- ₹611
- 52 Week High
- ₹1,210
- Open Price₹729
- Previous Close₹684
- Volume900
- 50 DMA₹727.46
- 100 DMA₹763.79
- 200 DMA₹837.18
Investment Returns
- Over 1 Month -5.92%
- Over 3 Month + 3.73%
- Over 6 Month -23.82%
- Over 1 Year -32.6%
Smart Investing Starts Here Start SIP with Remus Pharmaceuticals for Steady Growth!
Remus Pharmaceuticals Fundamentals Fundamentals refer to the financial data that companies report on a quarterly or annual basis.
- P/E Ratio
- 28.7
- PEG Ratio
- -
- Market Cap Cr
- 836
- P/B Ratio
- 2.7
- Average True Range
- 44.04
- EPS
- 24.53
- Dividend Yield
- 0.1
- MACD Signal
- 4.36
- RSI
- 47.29
- MFI
- 65.62
Remus Pharmaceuticals Financials
Remus Pharmaceuticals Technicals
EMA & SMA
Current Price
₹709.00
+
25
(3.65%)
- Bearish Moving Average 16
- Bullish Moving Average 0
- 20 Day
- ₹722.73
- 50 Day
- ₹727.46
- 100 Day
- ₹763.79
- 200 Day
- ₹837.18
Resistance and Support
709.98
- R3 759.07
- R2 744.03
- R1 725.02
- S1 690.97
- S2 675.93
- S3 656.92
Remus Pharmaceuticals Corporate Actions - Bonus, Splits, Dividends
| Date | Purpose | Remarks |
|---|---|---|
| 2025-11-10 | Quarterly Results & Interim Dividend | |
| 2025-05-17 | Audited Results, Dividend & Others | To consider 1. Bonus 2. Other business matters. Interim Dividend of Rs. 2 per equity share. |
| 2024-11-09 | Quarterly Results & Interim Dividend | To consider other business matters. Interim Dividend of Rs. 2 per equity share. |
| 2024-05-16 | Audited Results | |
| 2024-04-23 | Bonus issue & Interim Dividend |
Remus Pharmaceuticals F&O
About Remus Pharmaceuticals
- NSE Symbol
- REMUS
- BSE Symbol
- Managing Director
- Mr. Arpit Deepakkumar Shah
- ISIN
- INE0O5T01011
Similar Stocks to Remus Pharmaceuticals
Remus Pharmaceuticals FAQs
Remus Pharmaceuticals share price is ₹709 As on 14 January, 2026 | 21:06
The Market Cap of Remus Pharmaceuticals is ₹835.5 Cr As on 14 January, 2026 | 21:06
The P/E ratio of Remus Pharmaceuticals is 28.7 As on 14 January, 2026 | 21:06
The PB ratio of Remus Pharmaceuticals is 2.7 As on 14 January, 2026 | 21:06
Disclaimer: Investment in securities market are subject to market risks, read all the related documents carefully before investing. For detailed disclaimer please Click here.